Adalvo announces DCP filing of Solifenacin+Tamsulosin MR tablets

Adalvo announces ready-to-file dossier completion on Pomalidomide hard capsules development

We are pleased to share our exciting DCP schedule for 2021

Malta Life Sciences Park, San Gwann SGN3000

Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners. 

Our business is fueled by our passion for relentless commitment to the customer network we serve. No half measures - we are always on target.

Company

Purpose

News

Contact us

Terms of use

Privacy policy

Cookie Policy

Team

Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners. Our business is fueled by our passion for relentless commitment to the customer network we serve. No half measures - we are always on target.